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Background: open repair of intra-abdominal aortic aneurysm (AAA) is associated with lower torso ischaemia and
reperfusion
Objective: to examine the effect of antioxidants on the activation and sequestration of white blood cells and muscle injury
during AAA repair.
Method: forty-two patients undergoing elective infrarenal aneurysm repair, were randomised to either standard therapy
(22 patients) or standard therapy with additional multiantioxidant supplementation (20 patients). Vitamin E and C,
Allopurinol, N-acetylcysteine and mannitol was administered perioperatively. White blood cell count (WBC), serum
creatine kinase, aspartateaminotransferase, lactate and lipofuscine were measured.
Results: WBC remained higher after reperfusion in the antioxidant group (p 0.008). CK, ASAT and lipofuscine levels
were significantly lower after reperfusion in the antioxidant group (p 0.02, p 0.018, p 0.017).
Conclusion: multi-antioxidant supplementation was associated with a reduction in serum CK and ASAT after AAA
repair. This is likely due to a reduction in oxidative stress and a decreased leucocyte sequestration and activation.
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Polymorphonuclear adhesion, activation, migration
indicates ischaemia reperfusion injury1±12 and lead
to11,12 remote organ injury torso I-R.2,13±21
This damage is partly caused by oxygen-derived
free radicals (ODFR).22±24 Several studies have shown
that I-R damage can be ameliorated by antioxidants and
scavengers in both direct and indirect I-R models.25±34
The aim of the study was as same as indicated.
Patients and Methods
The protocol was approved by the local ethics com-
mittee. A power calculated was not performed and
the study was not blinded. After informed consent,
forty-two consecutive patients needing elective openPlease address all correspondence to: M. Wijnen, Department of
Surgery, St. Joseph Hospital, P.O.Box 7777, 5500 MB Veldhoven, The
Netherlands.
1078±5884/02/060486  05 $35.00/0 # 2002 Elsevier Science Ltd. Atransperitoneal surgery for an infrarenal abdominal
aneurysm were included over 36 months. Excluded
were patients with renal failure, needing artificial
support and those classified as A.S.A. 3 and higher.
Patients were randomised, by envelope to either
standard therapy or standard therapy supplemented
with antioxidants. The multi-antioxidant therapy
consisted of vitamin E, 5 days prior to the operation,
200 mg daily orally; vitamin C, on the morning of
operation, 2000 mg orally; Allopurinol, 1 day before
surgery 300 mg orally, and 300 mg intravenously
before the start of the operation; N-acetylcysteine,
150 mg/kg before the start of the operation and sub-
sequently 200 mg/kg in a drip over 12 hours; man-
nitol, 10% 500 ml, in 12 hours starting at the beginning
of surgery. Blood samples were taken before the start
of the antioxidant therapy (T Pre-op), before clamping
(T1), before release of the clamp (T2), 5 minutes after
release of the first leg (T3), during closure of the skin
(T4), 6 hours after release of the first clamp (T6) and 24
(Day 1) and 48 hrs (Day 2) after surgery. Preoperat-
ively an epidural catheter with bupivacaine and
sufentanyl was introduced and continued for three
days postoperatively.ll rights reserved.
Table 1. Patient demographics. Data are shown as mean and
(range).
Treated
N 20
Untreated
N 22
Age (range) 67 yr (51±75) 70 yr. (59±82) n.s.
Sex 19 m, 1 f 20 m, 2 f n.s.
Smoking (> 1 sig./day) 10 y, 10 n 15 y, 7 n n.s.
Diameter aneurysm
(range)
57 mm (45±80) 57 mm (45±85) n.s.
Table 2. Intra-operative details. Data are expressed as mean and
(range).
Treated
N 20
Untreated
N 22
Ischemia time
(minutes)
78 first leg
106 second leg
71 first leg
99 second leg
n.s.
n.s.
Graft type 12 tube 8 tube
8 aortobiiliacaal 8 aortobiiliacal p 0.034
6 aortobifemoral
Mean blood loss
(ml) (range)
2640
(650±5700)
1900
(600±4000)
n.s.
Hypotension min.
(systolic B.P.5
80 mmHg)
20 minutes 18 minutes n.s.
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vercuronium bromide and sufentanyl for induction,
followed by continuous infusion of propofol till the
end of surgery. A urinary catheter was placed after
induction of anaesthesia.
Serum total antioxidant capacity was measured
using a Randox antioxidant status kit (Randox
Laboratories Ltd, Diamond Rd., Crumlin, Co. Antrim,
United Kingdom). Serum lactate was measured on a
Vitros 950 analyser using standard Ektachem Slide
technology.
A white blood-cell count (WBC) was performed
using a Coulter GEN.S haematology analyser (Coulter
Corporation, Miami, Florida, U.S.A.).
Serum CK and ASAT activities were measured on a
Vitros 950 analyser using standard Ektachem Slide
technology. Lipofuscine was measured with the
method of Tsuchida et al.38 using the fluorescence
capacity of lipofuscine relative to quinine sulphate
at excitation and emission wavelengths of 345 and
430 nm.
Statistical analysis
To compare the two groups we used a non-parametric
test for unpaired samples (Mann±Whitney U test). To
compare the values at different points in time, we
used a non-parametric test for paired samples
(Wilcoxon signed rank test). Statistical significance
was accepted if p5 0.05.
Results
Patient characteristics are shown in Table 1 and
operative data are shown in Table 2.
No significant differences between groups were
found as to ischaemia time (p 0.67), blood loss
(p 0.78), time of hypotension (p 0.51) and serum
lactate values (p 0.43). One patient received a second
operation because of rebleeding and subsequently
died due to multiple organ failure.
Serum total antioxidant capacity was significantly
higher in the group receiving antioxidants at T1
(p5 0.001), T2 (p 0.049), T3 (p 0.016) and T4
(p 0.050). No statistical significant difference was
found after T4 (Fig. 1A).
In order to assess the effect of the multiantioxidant
supplementation it is necessary to compare the
changes within both groups, not the differences
between the groups.
WBC was decreased significantly in both groups at
T1 (median 5.9 and 6.5 109) and T2 (median 6.3and 6.4 109) when compared to pre-operative values
(median 8.1 and 7.7 109) (p5 0.02). After T3, WBC
was increased in the group receiving antioxidants
(median 7.8, 9.2 and 12.26 109). However, in
the standard treatment group WBC remained
significantly lower than pre-operative values until T6
(median 6.3, 7.2 and 10.056 109) (see Fig. 2). WBC was
significantly lower in the control group at T3
(p 0.027), T4 (p 0.008) and T6 (p 0.046). After
this time no differences were found (Fig. 1 B).
CK values were significantly lower in the anti-
oxidant group at day 1 (median 311 and 910 U/l)
compared to preoperative values (38 and 39 U/l)
(p 0.02) (Fig. 1C).
ASAT values were significantly lower in the anti-
oxidant group at day 1 (median 18 and 28 U/l)
compared to preoperative values (median 16 and
15 U/l) (p 0.018) (Fig. 1D).
Serum lipofuscine levels were significantly lower in
the antioxidant group at day 1 (median 0.14 and 0.18)
compared to preoperative values (median 0.30 and
0.33) (p 0.017) (Fig. 1E).
Discussion
Our results show that in the group receiving the anti-
oxidant supplementation more leucocytes remain inEur J Vasc Endovasc Surg Vol 23, June 2002
Fig. 1. (a) Serum total antioxidant capacity (mmol/l), (b) White blood-cell count (109/l), (c) Serum creatine kinase (U/l), (d) Aspartate
aminotransferase (U/l) and (e) Serum lipofuscine (g/l) in patients undergoing elective open repair of an infrarenal abdominal aneurysm
receiving either standard therapy (N 22) or standard therapy with multiantioxidant supplementation (N 20). Preoperative values
(Pre-op) and values before ischaemia (T1), before reperfusion (T2), 5 min. after reperfusion (T3), at closure of the skin (T4), 6 (T6) hrs after
reperfusion and 1 and 2 days after reperfusion are shown. Values as median and interquartile range.  indicates statistical significant
difference p5 0.05, Nwith antioxidants, Ðwithout antioxidants.
488 M. H. W. A. Wijnen et al.circulation after reperfusion. After an initial drop in
leucocytes at the start of the operation, explained by
the preoperative haemodilution and early sequestra-
tion, WBC increases much faster in the antioxidant
group. This suggests that more leucocytes areEur J Vasc Endovasc Surg Vol 23, June 2002sequestered in the non-antioxidant group, possibly
because of the antioxidants reducing the activation of
neutrophils. Once activated, neutrophils start produc-
ing not only ODFR but also several granule associated
proteins such as elastase.22,24 This can cause local
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as CK and ASAT. The fact that the rise in both
enzymes is less in the antioxidant group combined
with the faster rise in the leucocyte count in this
group may indicate that there is less seqestration of
leucocytes in the ischaemic lower torso in the antiox-
idant group. This may be caused by the reduced oxid-
ative stress in the treatment group. Oxidative stress
is hard to measure and quantify in vivo. We can only
measure the results of damage that is thought to be
caused by oxidative stress. In anticipation of the de-
velopment of more accurate markers for oxidative
stress caused by ischaemia reperfusion we use end-
products of lipid peroxidation such as malondialde-
hyde and lipofuscine as indicators for the amount of
oxidative stress. Lipofuscine is a pigment that is
formed as an end-result of in vivo lipid peroxidase in
organelles and is being used as a parameter of lipid
peroxidation in vitro and in vivo.38,39 The peak in lipo-
fuscine levels is expected about 24 hours after the
ischaemic event.40 We have found a difference in
serum lipofuscine levels between the study groups
indicating less lipid peroxidase in the antioxidant
group. In order to sort maximum antioxidant effect
during reperfusion we chose to administer large doses
of several antioxidants and scavengers. Not much
is known about the possible cummulative effect of
antioxidants and scavengers in vivo. It is very well
possible that the damage during I-R occurs due to
several different pathways and can be blocked by
several agents. This means that in a situation where
only one pathway is blocked the antioxidant effect
may be invisible, whereas where more pathways
are blocked this can result in a clinically detectable
effect. We therefore chose mannitol as a free radical
scavenger of superoxide and hydrogen peroxide,
N-acetylcysteine as a glutathione agonist, Allopurinol
as a free radical production inhibitor and the anti-
oxidant vitamins E and C, both decreasing lipid
peroxidation. All these substances have shown to
ameliorate I-R damage.26,28,31,32,34,42±45 The dose
chosen was the maximum daily dose allowed by the
manufacturers.
Even though the serum total antioxidant capacity in
the treatment group was significantly increased com-
pared to the non-treatment group, the absolute
increase was not spectacular. This may be due to the
fact that very little is known about increase in total
antioxidant capacity by multiantioxidant supple-
mentation.46,47 Thus, there may be still room for
improvement for the antioxidant supplementation.
Also the aortic aneurysm model is very difficult to
standardise and is subject to many variables and
better models are needed.Conclusion
In our study we have shown a reduction in serum CK
and ASAT after lower torso ischaemia±perfusion, most
likely caused by a reduction in oxidative stress and a
decreased leucocyte sequestration and activation by
administering a multi-antioxidant supplementation
to patients undergoing an infrarenal aneurysm repair.
Future studies will have to determine the impact on
clinical outcome of multiantioxidant supplementation
after lower torso ischaemia.
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